Evaluation of intravenous voriconazole in patients with compromised renal function

MLA

David R. Luke, et al. “Evaluation of Intravenous Voriconazole in Patients with Compromised Renal Function.” BMC Infectious Diseases, vol. 13, Mar. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1059506f018838311d04671e7f81a436&authtype=sso&custid=ns315887.

APA

David R. Luke, Craig M. Lilly, Joanne Meisner, Thomas Mayer, Verna L Welch, & Paul J. Ranauro. (2012). Evaluation of intravenous voriconazole in patients with compromised renal function. BMC Infectious Diseases, 13.

Chicago

David R. Luke, Craig M. Lilly, Joanne Meisner, Thomas Mayer, Verna L Welch, and Paul J. Ranauro. 2012. “Evaluation of Intravenous Voriconazole in Patients with Compromised Renal Function.” BMC Infectious Diseases 13 (March). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1059506f018838311d04671e7f81a436&authtype=sso&custid=ns315887.